Patient Debt Relief Act

The Patient Debt Relief Act amends the Social Security Act to impose new financial assistance and debt collection requirements on hospitals participating in the Medicare program, beginning January 1, 2028. Hospitals failing to comply face civil monetary penalties up to $1,000,000 per instance. This directly impacts hospital profitability by increasing compliance costs and limiting their ability to collect on patient debt. The bill also establishes a grant program under the Public Health Service Act for medical debt relief, which will reduce the overall pool of medical debt, thereby decreasing potential revenue for debt collection agencies and hospitals. The money trail for this legislation involves two primary mechanisms. First, hospitals will incur increased operational expenses for compliance with the new financial assistance and debt collection standards. Second, the grant program for medical debt relief will funnel funds to entities providing such relief, effectively reducing the total medical debt burden on consumers. This reduction in debt directly translates to less revenue for hospitals from collections and less business for third-party medical debt collectors. The bill does not specify an appropriation amount for the grant program at this stage, but its existence signals a future reduction in the addressable market for medical debt. Historically, legislative efforts to curb medical debt collection practices have negatively impacted hospital revenues and debt collection agencies. For example, in 2022, the three major credit bureaus (Equifax, Experian, and TransUnion) announced changes to how medical debt is reported, removing paid medical debt from credit reports and delaying reporting for unpaid medical debt. While not direct legislation, this regulatory shift reduced the leverage of debt collectors and hospitals, leading to increased write-offs. Companies like $HCA, $UHS, $TEN, and , which operate large hospital systems, saw increased bad debt provisions in subsequent quarters. Similarly, medical debt collection agencies like Transworld Systems Inc. (a subsidiary of $CASH) experienced reduced collection rates. Specific winners are consumers with medical debt, as the bill aims to provide relief and establish more favorable financial assistance programs. The losers are hospitals, including publicly traded entities like HCA Healthcare ($HCA), Universal Health Services ($UHS), Tenet Healthcare ($TEN), and LifePoint Health, due to increased compliance costs, reduced debt collection efficacy, and potential penalties. Medical debt collection agencies, such as those owned by Encore Capital Group ($CASH), will also see a reduction in their addressable market and collection rates. The bill has been referred to two committees, Energy and Commerce and Ways and Means, indicating a multi-committee review process. The effective date of January 1, 2028, provides a lead time for hospitals to adapt, but the long-term impact on their revenue streams from debt collection is clear. This bill is currently in the committee referral stage. The next steps involve committee hearings and potential markups. Given the effective date of January 1, 2028, the immediate market reaction will be muted, but investors should monitor its progression through Congress. If passed, the impact will gradually materialize as hospitals adjust their financial practices and the grant program is implemented.